Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6 Sarcoma 2 Thoracic 1 Genitourinary 1

Conditions

Metatropic dwarfism 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 335 Pemetrexed 276 Cisplatin 228 Paclitaxel 193 pembrolizumab 178 Erlotinib Hydrochloride 173 Docetaxel 154 Gemcitabine 126 Nivolumab 112 Bevacizumab 112 Radiotherapy 84 Etoposide 68 durvalumab 62 atezolizumab 59 Ipilimumab 51 Radiosurgery 49 osimertinib 42 130-nm albumin-bound paclitaxel 40 Afatinib 39 Gefitinib 38 Cetuximab 38 Albumin-Bound Paclitaxel 37 Taxes 32 Vinorelbine 29 Radiation 29 Topotecan 28 Drug Therapy 25 Crizotinib 23 Platinum 21 Dexamethasone 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Cilengitide × Thoracic × Clear all

NCT00842712 2017-01-13

CERTO

Merck KGaA, Darmstadt, Germany

Phase 2 Completed

232 enrolled 17 charts

Metatropic dwarfism, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡